Industry News

Apr 21, 2014
By BioPharm International Editors
Aastrom Biosciences will acquire Sanofi's CTRM business for $6.5 million.
Apr 17, 2014
By BioPharm International Editors
Immunovaccine's vaccine technology chosen for cervical, head, and neck cancer trials conducted by Dana-Farber Institute.
Apr 17, 2014
By BioPharm International Editors
Novartis receives FDA breakthrough therapy designation for Bexsero, a meningitis B vaccine.
Apr 11, 2014
By BioPharm International Editors
ThioBridge linker technology to attach different payloads to a range of antibodies
Apr 10, 2014
By BioPharm International Editors
The Advanced Tissue-engineered Human Ectypal Network Analyzer project team is developing realistic human organs for testing.
Apr 10, 2014
By BioPharm International Editors
uniQure appoints a new COO and vice president, Medical affairs.
Apr 07, 2014
By BioPharm International Editors
Novartis delivers 2 million treatments of its pediatric antimalarial to Zambia in collaboration with Malaria No More's Power of One campaign.
Apr 07, 2014
By BioPharm International Editors
Sanofi and Genzyme to resubmit FDA application for approval of Lemtrada, for the treatment of relapsing forms of multiple sclerosis.
Apr 07, 2014
By BioPharm International Editors
Immunovaccine reports enhanced cancer vaccine combination therapies at 2014 AACR Annual Meeting.
Apr 07, 2014
By BioPharm International Editors
New research finds that recurrent head and neck tumors have gene mutations that could be vulnerable to the cancer drug dasatinib.
native1_300x100
lorem ipsum